📰 Fim Phase News
Fim Phase News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Fim Phase. Real-time updates on events, politics, business and more.
May 30, 2024
30 May 2024 ORYZON to provide corporate progress updates at several events in June BIO International Convention 2024 ...
April 8, 2024
MADRID, Spain and CAMBRIDGE, Mass., April 08, 2024 -- Oryzon Genomics, S.A. , a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet...
April 5, 2024
5 April 2024 ORYZON to provide corporate progress updates at several events in April Investing in Oncology Forum 2024 ...
April 5, 2024
Investing in Oncology Forum 2024Van Lanschot Kempen Life Sciences Conference Swiss Biotech Day 2024LSX World CongressMADRID, Spain and BOSTON, Apr...
November 21, 2023
Funding provided by Nice & Green SA, a Swiss private investor This CB Program supersedes the previous oneTo extend its cash runway and continue the...
October 27, 2023
27.10.2023 - Positive aggregate safety data from vafidemstats fully enrolled PORTICO Phase IIb trial in Borderline Personality Disorder (BPD), consistent with safety data from seven completed clinical trials, supporting the drug is safe and ...
July 24, 2023
24 July 2023 ORYZON reports financial results and corporate updates for half-year ending June 30, 2023 Positive aggregate safety data from...
July 24, 2023
24.07.2023 - Positive aggregate safety data from vafidemstats PORTICO Phase IIb trial in Borderline Personality Disorder (BPD), consistent with safety data from seven completed clinical trials, supporting the drug is safe and well-toleratedContinues to enroll ...
June 27, 2023
27 June 2023 ORYZON Announces Voting Results from its 2023 Annual General Meeting of Shareholders All resolutions were approved. 35% of the issued shares represented. ...
May 9, 2023
BioEquity Europe 2023Foro Medcap BME 2023 VI Ibero-American Congress CEAPI 2023BIO International Conference 2023Jefferies Healthcare Conference 2023MidCap Paris 2023 MADRID and BOSTON, May 09, 2023 ... | May 9, 2023